| Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and … SC Palmer, A Hayen, P Macaskill, F Pellegrini, JC Craig, GJ Elder, ... Jama 305 (11), 1119-1127, 2011 | 943 | 2011 |
| Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies S Palmer, M Vecchio, JC Craig, M Tonelli, DW Johnson, A Nicolucci, ... Kidney international 84 (1), 179-191, 2013 | 907 | 2013 |
| Associations between hemodialysis access type and clinical outcomes: a systematic review P Ravani, SC Palmer, MJ Oliver, RR Quinn, JM MacRae, DJ Tai, ... Journal of the American Society of Nephrology 24 (3), 465-473, 2013 | 813 | 2013 |
| HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. SD Navaneethan, F Pansini, V Perkovic, C Manno, F Pellegrini, ... The Cochrane database of systematic reviews, CD007784-CD007784, 2009 | 512* | 2009 |
| Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta … SC Palmer, B Tendal, RA Mustafa, PO Vandvik, S Li, Q Hao, D Tunnicliffe, ... Bmj 372, 2021 | 506 | 2021 |
| Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis SC Palmer, D Mavridis, A Nicolucci, DW Johnson, M Tonelli, JC Craig, ... Jama 316 (3), 313-324, 2016 | 482 | 2016 |
| Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis SC Palmer, D Mavridis, E Navarese, JC Craig, M Tonelli, G Salanti, ... The Lancet 385 (9982), 2047-2056, 2015 | 466 | 2015 |
| Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease SC Palmer, SD Navaneethan, JC Craig, DW Johnson, M Tonelli, AX Garg, ... Annals of internal medicine 153 (1), 23-33, 2010 | 463 | 2010 |
| Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis SC Palmer, JC Craig, SD Navaneethan, M Tonelli, F Pellegrini, ... Annals of internal medicine 157 (4), 263-275, 2012 | 409 | 2012 |
| Effects of allopurinol on the progression of chronic kidney disease SV Badve, EM Pascoe, A Tiku, N Boudville, FG Brown, A Cass, P Clarke, ... New England Journal of Medicine 382 (26), 2504-2513, 2020 | 348 | 2020 |
| Meta-analysis: vitamin D compounds in chronic kidney disease SC Palmer, DO McGregor, P Macaskill, JC Craig, GJ Elder, GFM Strippoli Annals of internal medicine 147 (12), 840-853, 2007 | 302 | 2007 |
| Healthy dietary patterns and risk of mortality and ESRD in CKD: a meta-analysis of cohort studies JT Kelly, SC Palmer, SN Wai, M Ruospo, JJ Carrero, KL Campbell, ... Clinical Journal of the American Society of Nephrology 12 (2), 272-279, 2017 | 275 | 2017 |
| Consolidated criteria for strengthening reporting of health research involving indigenous peoples: the CONSIDER statement T Huria, SC Palmer, S Pitama, L Beckert, C Lacey, S Ewen, LT Smith BMC medical research methodology 19, 1-9, 2019 | 265 | 2019 |
| Acute kidney injury and prognosis after cardiopulmonary bypass: a meta-analysis of cohort studies JW Pickering, MT James, SC Palmer American Journal of Kidney Diseases 65 (2), 283-293, 2015 | 258 | 2015 |
| Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis B Bose, SV Badve, SS Hiremath, N Boudville, FG Brown, A Cass, ... Nephrology Dialysis Transplantation 29 (2), 406-413, 2014 | 258 | 2014 |
| Aldosterone antagonists for preventing the progression of chronic kidney disease D Bolignano, SC Palmer, SD Navaneethan, GFM Strippoli Cochrane Database of Systematic Reviews, 2014 | 253 | 2014 |
| Cognition in people with end-stage kidney disease treated with hemodialysis: a systematic review and meta-analysis E O’Lone, M Connors, P Masson, S Wu, PJ Kelly, D Gillespie, D Parker, ... American Journal of Kidney Diseases 67 (6), 925-935, 2016 | 250 | 2016 |
| Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis SC Palmer, L Di Micco, M Razavian, JC Craig, V Perkovic, F Pellegrini, ... Annals of internal medicine 156 (6), 445-459, 2012 | 250 | 2012 |
| Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials SD Navaneethan, SC Palmer, JC Craig, GJ Elder, GFM Strippoli American journal of kidney diseases 54 (4), 619-637, 2009 | 232 | 2009 |
| HMG CoA reductase inhibitors (statins) for dialysis patients SC Palmer, SD Navaneethan, JC Craig, DW Johnson, V Perkovic, ... Cochrane Database of Systematic Reviews, 2013 | 231 | 2013 |
Giovanni Strippoli, MD, PhD, MPH, MMUniversity of BariGeverifieerd e-mailadres voor uniba.it
